Epidemiology of Chagas Disease in the United States of America: A Short Review and Some Comments

Overview

Journal Pathogens

Date 2025 Jan 25

PMID 39860985

Authors

Stephen A Klotz

Affiliations

Soon will be listed here.

Abstract

The epidemiology of Chagas disease in humans has markedly changed within the past several decades in the United States of America. This report discusses autochthonous cases of Chagas disease as well as disease in immigrants from Latin American countries. Suggestions for epidemiology research and medical care are discussed given the evolving epidemiology of the disease in the United States of America.

References

Lynn M, Dye-Braumuller K, Beatty N, Dorn P, Klotz S, Stramer S . Evidence of likely autochthonous Chagas disease in the southwestern United States: A case series of Trypanosoma cruzi seropositive blood donors. Transfusion. 2022; 62(9):1808-1817. PMC: 9543114. DOI: 10.1111/trf.17026. View

Irish A, Whitman J, Clark E, Marcus R, Bern C . Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States. Emerg Infect Dis. 2022; 28(7):1313-1320. PMC: 9239882. DOI: 10.3201/eid2807.212221. View

Tibayrenc M, Ward P, Moya A, Ayala F . Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proc Natl Acad Sci U S A. 1986; 83(1):115-9. PMC: 322802. DOI: 10.1073/pnas.83.1.115. View

Martinez-Ibarra J, Paredes-Gonzalez E, Licon-Trillo A, Montanez-Valdez O, Rocha-Chavez G, Nogueda-Torres B . The biology of three Mexican-American species of Triatominae (Hemiptera: Reduviidae): Triatoma recurva, Triatoma protracta and Triatoma rubida. Mem Inst Oswaldo Cruz. 2012; 107(5):659-63. DOI: 10.1590/s0074-02762012000500013. View

Guzman-Marin E, Jimenez-Coello M, Puerto-Solis M, Ortega-Pacheco A, Acosta-Viana K . Influence of Triatoma dimidiata in Modulating the Virulence of Trypanosoma cruzi Mexican Strains. Interdiscip Perspect Infect Dis. 2012; 2012:328091. PMC: 3518057. DOI: 10.1155/2012/328091. View

de Paiva V, Belintani T, de Oliveira J, Galvao C, Aristeu da Rosa J . A review of the taxonomy and biology of Triatominae subspecies (Hemiptera: Reduviidae). Parasitol Res. 2022; 121(2):499-512. DOI: 10.1007/s00436-021-07414-2. View

Cucunuba Z, Gutierrez-Romero S, Ramirez J, Velasquez-Ortiz N, Ceccarelli S, Parra-Henao G . The epidemiology of Chagas disease in the Americas. Lancet Reg Health Am. 2024; 37:100881. PMC: 11519694. DOI: 10.1016/j.lana.2024.100881. View

Forsyth C, Higuita N, Hamer S, Ibarra-Cerdena C, Valdez-Tah A, Stigler Granados P . Climate change and Trypanosoma cruzi transmission in North and central America. Lancet Microbe. 2024; 5(10):100946. DOI: 10.1016/j.lanmic.2024.07.009. View

Cantey P, Stramer S, Townsend R, Kamel H, Ofafa K, Todd C . The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion. 2012; 52(9):1922-30. DOI: 10.1111/j.1537-2995.2012.03581.x. View

10.

Higuita N, Beatty N, Forsyth C, Henao-Martinez A, Manne-Goehler J . Chagas disease in the United States: a call for increased investment and collaborative research. Lancet Reg Health Am. 2024; 34:100768. PMC: 11127192. DOI: 10.1016/j.lana.2024.100768. View

11.

Klotz S, Dorn P, Mosbacher M, Schmidt J . Kissing bugs in the United States: risk for vector-borne disease in humans. Environ Health Insights. 2015; 8(Suppl 2):49-59. PMC: 4264683. DOI: 10.4137/EHI.S16003. View

12.

Rojas de Arias A, Monroy C, Guhl F, Sosa-Estani S, Santos W, Abad-Franch F . Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission. Mem Inst Oswaldo Cruz. 2022; 117:e210130. PMC: 9261920. DOI: 10.1590/0074-02760210130. View

13.

Bern C, Montgomery S . An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009; 49(5):e52-4. DOI: 10.1086/605091. View

14.

FAUST E . The etiologic agent of Chagas' disease in the United States. Bol Oficina Sanit Panam. 1949; 28(5):455-61. View

15.

Tibayrenc M, Ayala F . Reproductive clonality of pathogens: a perspective on pathogenic viruses, bacteria, fungi, and parasitic protozoa. Proc Natl Acad Sci U S A. 2012; 109(48):E3305-13. PMC: 3511763. DOI: 10.1073/pnas.1212452109. View

16.

Hill J, Teal E, Cross C, Sanchez Z, Webber M, Oxborough R . Using iNaturalist presence data to produce suitability maps for Triatoma protracta, T. rubida and T. recurva in the American Southwest, Texas and northern Mexico, to identify potential transmission zones of Chagas disease. Sci Rep. 2024; 14(1):26879. PMC: 11541903. DOI: 10.1038/s41598-024-76821-z. View

17.

Zeledon R, Dias J, de REZENDE J, Vargas L, Urbina A . Does a spontaneous cure for Chagas' disease exist?. Rev Soc Bras Med Trop. 1988; 21(1):15-20. DOI: 10.1590/s0037-86821988000100003. View

18.

Guarneri A, Lorenzo M . Triatomine physiology in the context of trypanosome infection. J Insect Physiol. 2016; 97:66-76. DOI: 10.1016/j.jinsphys.2016.07.005. View

19.

Dorn P, Buekens P, Hanford E . Whac-a-mole: future trends in Chagas transmission and the importance of a global perspective on disease control. Future Microbiol. 2007; 2(4):365-7. DOI: 10.2217/17460913.2.4.365. View

20.

DE Fuentes-Vicente J, Cabrera-Bravo M, Enriquez-Vara J, Bucio-Torres M, Gutierrez-Cabrera A, Vidal-Lopez D . Relationships between altitude, triatomine (Triatoma dimidiata) immune response and virulence of Trypanosoma cruzi, the causal agent of Chagas' disease. Med Vet Entomol. 2016; 31(1):63-71. DOI: 10.1111/mve.12198. View